- Home
- DAWN vs THCH Comparison
DAWN vs THCH Comparison
Compare DAWN & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DAWN | THCH |
|---|---|---|
| Founded | 2018 | 2018 |
| Country | United States | China |
| Employees | 181 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 970.3M | 85.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | DAWN | THCH |
|---|---|---|
| Price | $9.59 | $2.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $26.56 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 11.9K |
| Earning Date | 11-04-2025 | 12-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $133,672,000.00 | ★ $188,274,078.00 |
| Revenue This Year | $15.51 | N/A |
| Revenue Next Year | $49.99 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 31.11 | N/A |
| 52 Week Low | $5.64 | $1.95 |
| 52 Week High | $13.53 | $3.82 |
Technical Indicators
Market Signals| Indicator | DAWN | THCH |
|---|---|---|
| Relative Strength Index (RSI) | 58.46 | 35.78 |
| Support Level | $8.13 | $2.10 |
| Resistance Level | $9.82 | $2.29 |
| Average True Range (ATR) | 0.59 | 0.09 |
| MACD | 0.10 | -0.02 |
| Stochastic Oscillator | 64.40 | 15.00 |
Price Performance
Historical ComparisonAbout DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.